Macular degeneration
Macular degeneration: Excerpt from Handbook of Diseases
Macular degeneration, which is atrophy or degeneration of the macular disk, accounts for about 12% of all cases of blindness in the United States and for about 17% of new cases of blindness. It’s one of the causes of severe irreversible loss of central vision in people older than age 50. It affects slightly more women than men.
Two types of age-related macular degeneration occur. The dry, or atrophic, form is characterized by atrophic pigment epithelial changes and is usually associated with a slow, progressive distortion of straight lines or edges and central visual loss. The wet, or exudative, form causes rapid onset of visual impairment. It’s characterized by subretinal neovascularization that causes leakage, hemorrhage, and fibrovascular scar formation, which produce significant loss of central vision.
Causes
Age-related macular degeneration results from the formation of drusen (clumps of epithelium) or subretinal neovascular membrane in the macular region. It may be hereditary. Cigarette smoking and lack of antioxidants, such as vitamins C and E, may also enhance occurrence.
Underlying pathologic changes occur primarily at the level of the retinal pigment epithelium, Bruch’s membrane, and choriocapillaris in the macular region. Drusen (bumps), which are common in elderly people, appear as yellow deposits beneath the pigment epithelium and may be prominent in the macula.
Signs and symptoms
The patient notices a change in central vision; for example, he may notice a blank spot in the center of the page when reading.
Diagnosis
The following tests are used to diagnose macular degeneration:
❑ indirect ophthalmoscopy: may reveal gross macular changes
❑ Amsler’s grid: reveals central visual field distortion
❑ I.V. fluorescein angiography: may show leaking vessels as fluorescein dye flows into the tissues from the subretinal neovascular net.
Treatment
Laser photocoagulation reduces the incidence of severe visual loss in patients with subretinal neovascularization. Photodynamic therapy with vertepor-fin, a newer form of laser therapy, is effective in selected patients.
Special considerations
❑ Inform patients who have bilateral central vision loss of the low-vision rehabilitation services that are available to them.
❑ Special devices, such as low-vision optical aids, are available to improve the quality of life in patients with good peripheral vision.
Book Source Details
- Book Title: Handbook of Diseases
- Author(s): Springhouse
- Year of Publication: 2003
- Copyright Details: Handbook of Diseases, Copyright © 2003 Lippincott Williams & Wilkins.
More About Age-related macular degeneration
More Medical Textbooks Online about Age-related macular degeneration
Review other book chapters online related to Age-related macular degeneration:
Medical Books Excerpts
- SCOTOMA
- "Algorithmic Diagnosis of Symptoms and Signs" (2003)
- [ read ]
- Scotoma
- "Handbook of Signs & Symptoms (Third Edition)" (2006)
- [ read ]
- Scotoma
- "Professional Guide to Signs & Symptoms (Fifth Edition)" (2006)
- [ read ]
- Scotoma
- "The 10-Minute Diagnosis Manual: Symptoms and Signs in the Time-Limited Encounter" (2000)
- [ read ]
- Scotoma
- "Signs & Symptoms: A 2-in-1 Reference for Nurses" (2007)
- [ read ]
- Scotoma
- "Nursing: Interpreting Signs and Symptoms" (2007)
- [ read ]
Copyright notice for book excerpts: Copyright © 2008 Lippincott Williams & Wilkins. All rights reserved.
|
|
More About This Book:
Title: Handbook of Diseases
Authors: Springhouse
Publisher: Lippincott Williams & Wilkins
Copyright: 2003
ISBN: 1-58255-266-5
|
|
» Next page: Scotoma (Signs & Symptoms: A 2-in-1 Reference for Nurses)
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
